Showing posts with label Pension. Show all posts
Showing posts with label Pension. Show all posts

Tuesday, July 17, 2007

UPDATE 2-TD Bank to chip in C$3.8 bln for BCE takeover

(Reuters) - VANCOUVER, British Columbia, July 17 -
Toronto-Dominion Bank will put up C$3.8 billion , including C$500 million of equity, to finance the
buyout of BCE Inc. , Canada's biggest telecoms company,
the bank said on Tuesday.




TD said it has underwritten C$3.3 billion of a
C$34.3-billion credit facility and also provided a C$500
million equity bridge facility to the buyout consortium, which
is led by the Ontario Teachers' Pension Plan Board.


Read more at Reuters.com Bonds News

Monday, July 2, 2007

US STOCKS-Indexes rise on telecoms takeovers

(Reuters) - NEW YORK, July 2 - U.S. stocks rose on Monday,
boosted by takeover news in the telecommunications sector.




Canada's largest telephone company, BCE Inc
, agreed to a US$32.8 billion buyout, excluding debt,
from a group that includes the Ontario Teachers Pension Plan on
Saturday, in the biggest buyout in Canadian corporate history.
For details, see [ID:nN02315411].


Read more at Reuters.com Bonds News

US STOCKS-Futures up on telecoms takeovers, data eyed

(Reuters) - NEW YORK, July 2 - U.S. stock index futures rose
on Monday, boosted by takeover news in the telecommunications
sector and before a report on manufacturing activity that could
give clues on the outlook for profits.




Canada's largest telephone company, BCE Inc
, agreed to a US$32.8 billion buyout, excluding debt,
from a group that includes the Ontario Teachers Pension Plan on
Saturday, in the biggest buyout in Canadian corporate history.
For details, see [ID:nN02315411].


Read more at Reuters.com Bonds News

Friday, June 29, 2007

UPDATE 1-Path for generic biologics clears US Senate panel

(Reuters) - WASHINGTON, June 27 - A U.S. Senate panel voted
on Wednesday to set a path for generic drugmakers to seek
approval of cheaper, copycat versions of expensive
biotechnology medicines.




Brand-name manufacturers would receive 12 years of
exclusive marketing time before generic competition could start
under a bill that cleared the Senate Health, Education, Labor
and Pensions Committee by a voice vote.


Read more at Reuters.com Government Filings News